Synthetic Biology Market Revenue and Value Chain 2016-2026
Synthetic Biology is one of the breakthrough technologies developed by mankind from chemistry, biology, computer science and engineering which ultimately changed the approach towards therapeutics.
Synthetic Biology is one of the breakthrough technologies developed by mankind from chemistry, biology, computer science and engineering which ultimately changed the approach towards therapeutics.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Report Description<br />
<strong>Synthetic</strong> <strong>Biology</strong> is one of the breakthrough technologies developed by mankind from<br />
chemistry, biology, computer science <strong>and</strong> engineering which ultimately changed the approach<br />
towards therapeutics. It has a varied areas of applications in biofuels, industrial enzymes,<br />
vaccine <strong>and</strong> antibody production, bio-based chemicals <strong>and</strong> synthetic biology life science<br />
research. <strong>Synthetic</strong> biologists develop such biological systems using by molding the core<br />
components (genetic circuits, part of enzymes <strong>and</strong> metabolic pathways) <strong>and</strong> underst<strong>and</strong>ing their<br />
performance while using these smaller parts or devices into the specific integrated systems. The<br />
production of new medicines is now done by using synthetic biology on a cellular, molecular <strong>and</strong><br />
genetic level to address the emerging health issues.<br />
<strong>Synthetic</strong> <strong>Biology</strong> <strong>Market</strong>: Drivers & Restraints<br />
Internationally, companies have started investing in <strong>Synthetic</strong> biology as many governmental<br />
bodies are turning towards biomass <strong>and</strong> climate change. In past few years synthetic biology has<br />
gained industrial interest which has a large scale applications <strong>and</strong> potential of new gene editing<br />
techniques are some of the drivers for this market. Traditional medicines are being replaced by<br />
genetically engineered products, DNA sequencing <strong>and</strong> DNA synthesis technologies. This market<br />
though has a potential there with any advances there are risks <strong>and</strong> hindrance like government<br />
regulations <strong>and</strong> policies, biosafety <strong>and</strong> biosecurity issues, bio-war but these issues are being<br />
addressed by the regulatory bodies <strong>and</strong> research institutions.
Change language